Tag: risk management

The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...

The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...

When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...

It may seem odd to be discussing sourcing challenges considering the overwhelming evidence we now have...

The current coronavirus epidemic and subsequent shutdown of travel to and from affected areas in China...

Farewell to the Blockbuster? The blockbuster drug era is widely reported to be coming to an end. Last...